U.S. approves first drug treatment for obstructive sleep apnoea

U.S. approves first drug treatment for obstructive sleep apnoea

The drug Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood pressure The drug Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood pressure Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu

Leave a Reply

Your email address will not be published. Required fields are marked *